Literature DB >> 12472957

Clinical relevance of viral dynamics and genotypes in hepatitis B virus.

Stephen A Locarnini1.   

Abstract

Advances in molecular diagnostic technology make it possible to accurately measure viral loads and this has allowed the detailed study of viral dynamics of HIV, hepatitis C virus (HCV) and hepatitis B virus (HBV). Following antiviral therapy, there are at least two phases of viral load decay: one corresponding to clearance of free virions and a second, slower phase corresponding to eradication of infected cells. Application of mathematical models allows for the assessment of antiviral efficacy and improved design of therapeutic regimens. The clinical application of these tools should help optimize patient outcome. Another advantage of molecular diagnostics is characterization of the heterogeneity of viruses in particular patient populations under selective pressure situations. The HBV can be classified into seven major genotypes (A-G) that have mainly a geographic distribution. Recent genotypic studies have revealed the clinical and therapeutic relevance of viral genotyping in HBV infections. Copyright 2002 Blackwell Publishing Asia Pty Ltd

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12472957     DOI: 10.1046/j.1440-1746.17.s3.21.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  8 in total

1.  Prevalence of HBV genotypes among Egyptian hepatitis patients.

Authors:  Iman A El Aziz Khaled; Ola M Mahmoud; Abeya F Saleh; Emad E Bioumie
Journal:  Mol Biol Rep       Date:  2010-12-23       Impact factor: 2.316

2.  Early viral kinetics of telbivudine and entecavir: results of a 12-week randomized exploratory study with patients with HBeAg-positive chronic hepatitis B.

Authors:  Dong Jin Suh; Soon Ho Um; Eva Herrmann; Ju-Hyun Kim; Young Sok Lee; Heon Ju Lee; Myung Seok Lee; Youn-Jae Lee; Weibin Bao; Patricia Lopez; Han Chu Lee; Claudio Avila; Stefan Zeuzem
Journal:  Antimicrob Agents Chemother       Date:  2009-12-22       Impact factor: 5.191

3.  Molecular analysis of hepatitis B virus isolates in Mexico: predominant circulation of hepatitis B virus genotype H.

Authors:  Cosme Alvarado-Esquivel; Erwin Sablon; Carlos-Jesús Conde-González; Luis Juárez-Figueroa; Lilia Ruiz-Maya; Sergio Aguilar-Benavides
Journal:  World J Gastroenterol       Date:  2006-10-28       Impact factor: 5.742

4.  Evaluation of the INNO-LiPA HBV genotyping assay for determination of hepatitis B virus genotype.

Authors:  Carla Osiowy; Elizabeth Giles
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

5.  Molecular epidemiological study of hepatitis B virus in blood donors from five Chinese blood centers.

Authors:  Yu Liu; Jingxing Wang; Yi Huang; Tonghan Yang; Xiaoming Guo; Julin Li; Guoxin Wen; Zhongqiao Yun; Peibin Zeng; Miao He; Min Xu; Gui Liu; Ling Ke; David Wright; Jing Liu; Kenrad Nelson; Hua Shan
Journal:  Arch Virol       Date:  2012-06-06       Impact factor: 2.574

6.  Platelet count is associated with sustained virological response rates in treatments for chronic hepatitis C.

Authors:  Baek Gyu Jun; Eui Ju Park; Woong Cheul Lee; Jae Young Jang; Soung Won Jeong; Young Don Kim; Gab Jin Cheon; Young Sin Cho; Sae Hwan Lee; Hong Soo Kim; Yun Nah Lee; Sang Gyune Kim; Young Seok Kim; Boo Sung Kim
Journal:  Korean J Intern Med       Date:  2018-03-14       Impact factor: 2.884

7.  HBVRegDB: annotation, comparison, detection and visualization of regulatory elements in hepatitis B virus sequences.

Authors:  Nattanan Panjaworayan; Stephan K Roessner; Andrew E Firth; Chris M Brown
Journal:  Virol J       Date:  2007-12-17       Impact factor: 4.099

8.  Early Viral Kinetics with Telbivudine, Tenofovir or Combination of Both in Immunotolerant Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B.

Authors:  Nancy W Y Leung; Eva Herrmann; George K K Lau; Henry L Y Chan; Tokutei M K So; Stefan Zeuzem; Yu Dong; Aldo Trylesinski; Nikolai V Naoumov
Journal:  Infect Dis Ther       Date:  2014-09-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.